Clinical Trial Update: Evolutionary Therapy for Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

This update reports an ongoing Phase 2 clinical trial of an evolutionary therapy for rhabdomyosarcoma, sponsored by H. Lee Moffitt Cancer Center, currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Rhabdomyosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING